Keyword: Pharmaceuticals

News

Abbott Lifts 2012 Forecast

18.04.2012 - Abbott Laboratories reported better-than-expected quarterly sales and earnings, fueled by strong demand for its Humira arthritis drug and its wide array of prescription medicines...

News

US Top Court Rules for Generic Drugmaker on Patent

18.04.2012 - The U.S. Supreme Court ruled on Tuesday in favor of a generic drugmaker in a case over how companies can fight brand-name rivals in an effort to get their cheaper medicines to...

Plant Construction & Process Technology

India’s Insights into Serialization

17.04.2012 - Securing Medication - India is among the first countries to require pharmaceutical companies to serialize their products. PharmaSecure works with Indian manufacturers to mark...

Chemistry & Life Sciences

Chemical Control Legislation in India

17.04.2012 - Checks and Balances on Chemicals - The Indian chemical industry is very diverse and covers basic chemicals and their intermediates, petrochemicals, fertilizers, paints, pesticides...

News

Piramal Sees $1.5 Billion Revenue from Potential Alzheimer's Drug

16.04.2012 - Indian drugmaker Piramal Healthcare sees revenue potential of $1.5 billion from its new florbetaben molecule, a possible Alzheimer's treatment acquired by the company in a deal...

News

Merck Serono Sets Up Biotech Incubator in Israel

15.04.2012 - Merck Serono, the biopharmaceutical division of German drugs and chemicals group Merck KGaA, inaugurated on Sunday a biotech incubator at Inter-Lab, its research and development...

News

Helsinn Advanced Synthesis Successfully Inspected by FDA

13.04.2012 - Biasca, the Swiss-based APIs (Active Pharmaceutical Ingredients) and HPAPIs (Highly Potent Active Pharmaceutical Ingredients) contract manufacturing company of the Helsinn Group...

News

Biosimilar Remicade Accepted for EU Drug Review

13.04.2012 - Europe's drugs watchdog is to evaluate a copycat version of the best-selling biotech drug Remicade, used to treat arthritis, in a move that underscores how the market for so-called...